2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$37.25+$1.38 (+3.85%)
Price as of Oct 02, 2026 4:49 PM EDT- $757.1MMarket Cap
- -6.91%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$37.25+$1.38 (+3.85%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $35.87 | ||
Change | +$0.13 (+0.36%) | ||
Open | $35.58 | ||
High | $36.23 | ||
Low | $35.18 | ||
Previous Close | $35.74 | ||
Volume | 275,073 | ||
30-Day Average Volume | 247,720 | ||
1-Week Change | 5.72% | ||
1-Month Change | -6.22% | ||
1-Year Change | -6.91% | ||
3-Year Change | 199.51% | ||
5-Year Change | 88.10% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.5B | ||
Market Cap | $757.1M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $396.7M | ||
Net Income | $21.7M | ||
Free Cash Flow | $5.2M | ||
EBIT | $42.5M | ||
EBITDA | $55.9M | ||
Net Working Capital | $619.0M | ||
EPS | $0.53 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 68 | ||
PEG | -7 | ||
Price/Free Cash Flow | 145 | ||
Price/Operating Cash Flow | 31 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.34% | ||
Trailing Annual Dividend Yield | 1.34% | ||
Ex-Dividend Date | 09/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield